Concepedia

P. Collis

PC

4

Publications

937

Citations

4

H-Index

1989

Active since

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

P. Collis is an author at BioCryst Pharmaceuticals (United States) specializing in gene expression, transcriptional regulation, and molecular genetics.

Top concepts

Publications per year

1989–2016

4

Publications

4

Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

Rob Schuurman, Monique Nijhuis, Remko van Leeuwen et al. · The Journal of Infectious Diseases · 1995 · 517 citations

A dominant control region from the human β-globin locus conferring integration site-independent gene expression

Dale Talbot, P. Collis, Michael Antoniou et al. · Nature · 1989 · 333 citations · Full text

, , +7

A Clinical Trial of Intravenous Peramivir Compared with Oral Oseltamivir for the Treatment of Seasonal Influenza in Hospitalized Adults

Michael G. Ison, David S.C. Hui, Kate Clezy et al. · Antiviral Therapy · 2012 · 72 citations

Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study

Melanie Cornpropst, P. Collis, J. Collier et al. · Allergy · 2016 · 15 citations

Rows per page

1–4 of 4